
Emily Ann Cordas
Examiner (ID: 8282, Phone: (571)272-2905 , Office: P/1651 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632, 1651 |
| Total Applications | 642 |
| Issued Applications | 272 |
| Pending Applications | 121 |
| Abandoned Applications | 287 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18575769
[patent_doc_number] => 11732285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Selective enrichment media and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/814021
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16049
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814021
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814021 | Selective enrichment media and uses thereof | Mar 9, 2020 | Issued |
Array
(
[id] => 17609803
[patent_doc_number] => 20220152082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => Methods for Cancer Diagnosis, Prognosis or Treatment
[patent_app_type] => utility
[patent_app_number] => 17/436920
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436920 | Methods for Cancer Diagnosis, Prognosis or Treatment | Mar 5, 2020 | Abandoned |
Array
(
[id] => 20401304
[patent_doc_number] => 12491264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Compositions and methods for the diagnosis and treatment of retinopathies
[patent_app_type] => utility
[patent_app_number] => 17/436419
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 16
[patent_no_of_words] => 30154
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436419
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/436419 | Compositions and methods for the diagnosis and treatment of retinopathies | Mar 3, 2020 | Issued |
Array
(
[id] => 20227374
[patent_doc_number] => 12416017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration
[patent_app_type] => utility
[patent_app_number] => 17/431937
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 36
[patent_no_of_words] => 21857
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431937 | Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration | Feb 20, 2020 | Issued |
Array
(
[id] => 20227374
[patent_doc_number] => 12416017
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration
[patent_app_type] => utility
[patent_app_number] => 17/431937
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 36
[patent_no_of_words] => 21857
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431937 | Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration | Feb 20, 2020 | Issued |
Array
(
[id] => 16085329
[patent_doc_number] => 20200196651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => COHESIVE THIN LIQUIDS TO PROMOTE SAFE SWALLOWING IN DYSPHAGIC PATIENTS
[patent_app_type] => utility
[patent_app_number] => 16/790286
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790286
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790286 | Cohesive thin liquids to promote safe swallowing in dysphagic patients | Feb 12, 2020 | Issued |
Array
(
[id] => 17719088
[patent_doc_number] => 20220211807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => TREATMENT OF CILIOPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/431146
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431146 | TREATMENT OF CILIOPATHIES | Feb 12, 2020 | Pending |
Array
(
[id] => 18930976
[patent_doc_number] => 11883370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-30
[patent_title] => Extensional viscosity to promote safe swallowing of food boluses
[patent_app_type] => utility
[patent_app_number] => 16/789022
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10892
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16789022
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/789022 | Extensional viscosity to promote safe swallowing of food boluses | Feb 11, 2020 | Issued |
Array
(
[id] => 18418524
[patent_doc_number] => 20230172982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Elimination of BCMA-positive malignancies by CAR expressing NK cells
[patent_app_type] => utility
[patent_app_number] => 17/795735
[patent_app_country] => US
[patent_app_date] => 2020-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795735
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795735 | Elimination of BCMA-positive malignancies by CAR expressing NK cells | Jan 29, 2020 | Pending |
Array
(
[id] => 16296306
[patent_doc_number] => 20200282029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => METHODS FOR TREATING OSTEOARTHRITIS PAIN
[patent_app_type] => utility
[patent_app_number] => 16/745773
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16745773
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/745773 | METHODS FOR TREATING OSTEOARTHRITIS PAIN | Jan 16, 2020 | Abandoned |
Array
(
[id] => 17548137
[patent_doc_number] => 20220119478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => ADVANCED CHIMERIC ANTIGEN RECEPTOR VECTORS FOR TARGETING SOLID TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/423059
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423059 | ADVANCED CHIMERIC ANTIGEN RECEPTOR VECTORS FOR TARGETING SOLID TUMORS | Jan 14, 2020 | Abandoned |
Array
(
[id] => 19440026
[patent_doc_number] => 12090253
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-09-17
[patent_title] => Bioengineered allogeneic blood vessel
[patent_app_type] => utility
[patent_app_number] => 16/728138
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 107
[patent_no_of_words] => 12783
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16728138
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/728138 | Bioengineered allogeneic blood vessel | Dec 26, 2019 | Issued |
Array
(
[id] => 17519274
[patent_doc_number] => 20220105122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => THERAPEUTIC AND PROPHYLACTIC AGENT FOR GLIOMA, BRAIN TUMOR MALIGNANCY MARKER, BRAIN TUMOR PROGNOSTIC MARKER, METHOD FOR DETERMINING MALIGNANCY AND PROGNOSIS OF BRAIN TUMOR AND ANTIBODY INHIBITING TUMOR PROLIFERATION
[patent_app_type] => utility
[patent_app_number] => 17/419154
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17419154
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/419154 | THERAPEUTIC AND PROPHYLACTIC AGENT FOR GLIOMA, BRAIN TUMOR MALIGNANCY MARKER, BRAIN TUMOR PROGNOSTIC MARKER, METHOD FOR DETERMINING MALIGNANCY AND PROGNOSIS OF BRAIN TUMOR AND ANTIBODY INHIBITING TUMOR PROLIFERATION | Dec 26, 2019 | Pending |
Array
(
[id] => 17604241
[patent_doc_number] => 11332714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Cell system and method for storing cells
[patent_app_type] => utility
[patent_app_number] => 16/718284
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15720
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16718284
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/718284 | Cell system and method for storing cells | Dec 17, 2019 | Issued |
Array
(
[id] => 16177196
[patent_doc_number] => 20200224164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => PLATELETS AS DELIVERY AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/698583
[patent_app_country] => US
[patent_app_date] => 2019-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16698583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/698583 | PLATELETS AS DELIVERY AGENTS | Nov 26, 2019 | Abandoned |
Array
(
[id] => 15708703
[patent_doc_number] => 20200101117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => METHODS OF CARDIAC REPAIR
[patent_app_type] => utility
[patent_app_number] => 16/693998
[patent_app_country] => US
[patent_app_date] => 2019-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16693998
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/693998 | Methods of cardiac repair | Nov 24, 2019 | Issued |
Array
(
[id] => 17334695
[patent_doc_number] => 20220001026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => USE OF MRNA ENCODING OX40L TO TREAT CANCER IN HUMAN PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/290571
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290571
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290571 | USE OF MRNA ENCODING OX40L TO TREAT CANCER IN HUMAN PATIENTS | Nov 7, 2019 | Abandoned |
Array
(
[id] => 16086381
[patent_doc_number] => 20200197177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => POUCH-LIKE CONSTRUCT FOR PREVENTING HEART DISTENSION
[patent_app_type] => utility
[patent_app_number] => 16/677323
[patent_app_country] => US
[patent_app_date] => 2019-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16677323
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/677323 | Pouch-like construct for preventing heart distension | Nov 6, 2019 | Issued |
Array
(
[id] => 16621793
[patent_doc_number] => 20210040446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => Method for Producing an Exosome Containing Therapeutic Agent
[patent_app_type] => utility
[patent_app_number] => 16/668655
[patent_app_country] => US
[patent_app_date] => 2019-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16668655
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/668655 | Method for producing an exosome containing therapeutic agent | Oct 29, 2019 | Issued |
Array
(
[id] => 15965495
[patent_doc_number] => 20200166499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => THREE-DIMENSIONAL CELL CULTURE MODEL OF THE HUMAN SWEAT GLAND FOR THE ANALYSIS OF STRESS-ASSOCIATED SWEATING PROCESSES
[patent_app_type] => utility
[patent_app_number] => 16/584350
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5598
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/584350 | THREE-DIMENSIONAL CELL CULTURE MODEL OF THE HUMAN SWEAT GLAND FOR THE ANALYSIS OF STRESS-ASSOCIATED SWEATING PROCESSES | Sep 25, 2019 | Abandoned |